文獻(xiàn)標(biāo)題: 1.Development and evaluation of chitosan based oral controlled matrix tablets of?losartan?potassium J Pharm Investig.?2012 Jul;2(3):157-61. doi: 10.4103/2230-973X.104399. 2.Response criteria of tolvaptan for the treatment of hepatic edema J Gastroenterol. 2017 Jun 29. 3.Hepatol Res.?2017 Oct 6. doi: 10.1111/hepr.12988. [Epub ahead of print] Increased?serum?C-reactive?protein?and?decreased?urinary?aquaporin?2?levels?are?predictive?of the?efficacy?of?tolvaptan?in?patients?with?liver?cirrhosis. 4.Highly linear pH gradients for analyzing monoclonal antibody charge heterogeneity in the alkaline range. 5.An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles 6.Anatol J Cardiol.?2017 Sep;18(3):213-214. doi: 10.14744/AnatolJCardiol.2017.8033. Tolvaptan?in the very elderly with acute decompensated heart failure- a therapeutic option worth of consideration. 7.紫外-可見(jiàn)分光光度法測(cè)定依達(dá)拉奉注射液中的亞硫酸氫鈉含量 8.Anatol J Cardiol. 2017 Sep;18(3):213-214. doi: 10.14744/AnatolJCardiol.2017.8033. Tolvaptan in the very elderly with acute decompensated heart failure- a therapeutic option worth of consideration. 備注: 將符合要求的文獻(xiàn)PDF格式打包上傳   [更多]

求購(gòu)熊去氧膽酸、牛磺熊去氧膽酸膠囊注冊(cè)標(biāo)準(zhǔn)；都需要最新的標(biāo)準(zhǔn)   [更多]

標(biāo)題： 1、Comparative Pharmacokinetics of the New Oral Cephalosporins 2、Jiang X, Wang N, Zhang Z J, et al. Pharmacokinetics and comparative bioavailability of two terbinafine hydrochloride formulations after single-dose administration in Chinese healthy subjects.[J]. Arzneimittel-Forschung, 2008, 58(7):363-366. 3、Almeida S, Filipe A, Vallée F, et al. Comparative bioavailability of two formulations of terbinafine. Data from a cross-over, randomised, open-label bioequivalence study in healthy volunteers.[J]. Arzneimittel-Forschung, 2004, 54(11):757-62. 4、De-Oliveira C, Barrientos-Astigarraga R, De-Moraes M, et al. Terbinafine quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry: application to a bioequivalence study.[J]. Therapeutic Drug Monitoring, 2001, 23(6):709. 5、Impact of moisture and magnesium stearate functionality on manufacturability of wet granulated metformin tablets 6、The?antipruritic?effect?of?5%?doxepin?cream?in?patients?with?eczematousdermatitis.?Doxepin?Study Group. 7、Photoisomerization of Ionic Liquid Ammonium Cinnamates: One-Pot Synthesis?Isolation of Z-Cinnamic Acids 8、[Pharmacokinetics and bioequivalence of atorvastatin calcium tablets in healthy male Chinese volunteers]. 9、Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Lowering With Atorvastatin in Patients of South Asian Compared With European Origin: Insights From the Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration (ACTFAST) Study 10、Do the lipid responses to rosuvastatin and atorvastatin differ between Chinese and Caucasians? Comparison of the DISCOVERY-Hong Kong study with other DISCOVERY studies 備注：將符合的文獻(xiàn)PDF格式打包上傳   [更多]

地西泮注射液津藥和平（天津）最新說(shuō)明書(shū)，要求通過(guò)一致性評(píng)價(jià)。要求：1.附件說(shuō)明書(shū)。2.內(nèi)容完整且清晰。   [更多]

求購(gòu)戈舍瑞林植入劑復(fù)核標(biāo)準(zhǔn) 標(biāo)準(zhǔn)號(hào)JX20010474   [更多]

查詢(xún)一個(gè)藥品的銷(xiāo)售數(shù)據(jù)   [更多]

任務(wù)描述：根據(jù)文獻(xiàn)題目等相關(guān)信息，在網(wǎng)上下載準(zhǔn)確的文獻(xiàn)，每篇文獻(xiàn)1元。文獻(xiàn)數(shù)量有301篇，均是中文文獻(xiàn)，需要找三個(gè)威客來(lái)下載文獻(xiàn)，每人下載100篇。 要求：1.下載文件類(lèi)型為PDF，內(nèi)容完整，文件名稱(chēng)要包含文獻(xiàn)題目。 2.投稿的用戶(hù)自己有下載文獻(xiàn)的資源或途徑，我方不提供文獻(xiàn)庫(kù)的賬號(hào)等。 3.完成時(shí)間：2015年8月24日之前。4.一旦接受此項(xiàng)任務(wù)，不得中途退出。   [更多]

“7200元請(qǐng)人對(duì)藥品按ATC分類(lèi)標(biāo)準(zhǔn)進(jìn)行分類(lèi)”，該任務(wù)中每組做得好的多獎(jiǎng)勵(lì)一百元。獎(jiǎng)勵(lì)領(lǐng)取在此交稿   [更多]

需求文獻(xiàn)： 1、DAWSON PA， KARPEN SJ． Bile acids reach out to the spinal cord： new insights to the pathogenesis of itch and analgesia in cholestatic liver disease ［J］． Hepatology， 2014， 59 （4）：1638－1641． 2、Kremer AE, van Dijk R, Leckie P, et al. Serum autotaxin is increased in pruirtus of cholestasis, but not of other oirgin, and responds to therapeutic interventions[J]. Hepatology, 2012(56): 1391-1400. 3、Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis. Sumeyye Samur,Matthew Klebanoff,Reiner Banken,Daniel S. Pratt. 《Hepatology》 , 2017 , 65 (3) :920. 4、Obeticholic acid for PBC. Hugh Thomas. Nature Reviews Gastroenterology & Hepatology 13, 558-559 (2016). 5、Emerging and future therapies for nonalcoholic steatohepatitis in adults. Gesthimani Mintziori , Stergios A. Polyzos. 《Expert Opinion on Pharmacotherapy》 , 2016 , 17 (14) :1 -10. 6、9、Obeticholic acid for the treatment of primary biliary cirrhosis. Trivedi PJ, Hirschfield GM, Gershwin ME. Expert Rev Clin Pharmacol. 2016;9(1):13-26. doi:10.1586/17512433.2015.1092381. Epub 2015 Nov 7. 7、Kowdley K，Nevens F，Andreone P，et al． The first new trials for primary biliary cirrhosis in a decade: an international program evaluating the farnesoid X receptor agonist obeticholic acid［J］． Gastroenterology，2015，1481 ( 4) : S991-S992． 8、Treatment of Non-Alcoholic Fatty Liver Disease . Scherer A., Dufour J.-F. 9、Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers. Pencek R, Marmon T, Roth JD, Liberman A, Hooshmand-Rad R, Young MA. Diabetes Obes Metab. 2016 Sep;18 (9):936-40. doi: 10.1111/dom.12681. Epub 2016 Jun 6. 10、Metabolite profiling of CHO?cells with different growth characteristic 11、Sun, Zhaoyun; Peng, Xinhua; Dong, Xiongzi; Shi, Wenwen - Asian Journal of Chemistry, 2012, vol. 24, # 2, p. 929 - 930 要求：下載符合需求的文獻(xiàn)PDF格式打包上傳   [更多]

求購(gòu)《中國(guó)藥典2010年版》第二增補(bǔ)本2013 要求： 1.PDF格式的文件； 2.文件上不能添加任何水印； 3.文件不能加密； 有這個(gè)文件并且符合上面要求的，請(qǐng)投標(biāo)！   [更多]